• Consensus Rating: Hold
  • Consensus Price Target: $52.92
  • Forecasted Upside: 6.32 %
  • Number of Analysts: 11
  • Breakdown:
  • 2 Sell Ratings
  • 5 Hold Ratings
  • 3 Buy Ratings
  • 1 Strong Buy Ratings
$49.77
▲ +1.64 (3.41%)

This chart shows the closing price for CGNX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cognex Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CGNX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CGNX

Analyst Price Target is $52.92
▲ +6.32% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Cognex in the last 3 months. The average price target is $52.92, with a high forecast of $80.00 and a low forecast of $40.00. The average price target represents a 6.32% upside from the last price of $49.77.

This chart shows the closing price for CGNX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 11 polled investment analysts is to hold stock in Cognex. This rating has held steady since February 2022, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
6/16/2021
  • 1 strong buy ratings
  • 1 buy ratings
  • 6 hold ratings
  • 0 sell ratings
9/14/2021
  • 1 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/13/2021
  • 1 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 2 sell ratings
3/13/2022
  • 1 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 2 sell ratings
6/11/2022
  • 1 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 2 sell ratings
9/9/2022
  • 1 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 2 sell ratings
11/8/2022
  • 1 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 2 sell ratings
12/8/2022

Latest Recommendations

  • 1 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/22/2022CowenDowngradeOutperform ➝ Market Perform$55.00 ➝ $50.00Low
11/22/2022CowenDowngradeOutperform ➝ Market Perform$55.00 ➝ $50.00Low
11/6/2022Raymond JamesLower Target$75.00 ➝ $65.00Low
11/4/2022Needham & Company LLCBoost TargetBuy$52.00 ➝ $54.00Low
10/12/2022Morgan StanleyLower TargetEqual Weight$45.00 ➝ $41.00Low
9/20/2022Needham & Company LLCBoost TargetBuy$50.00 ➝ $52.00Low
8/12/2022JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$40.00Low
8/9/2022Daiwa Capital MarketsLower Target$54.00N/A
8/4/2022Morgan StanleyLower TargetEqual Weight$52.00 ➝ $45.00N/A
8/3/2022Raymond JamesLower TargetStrong-Buy$80.00 ➝ $75.00Low
8/3/2022CowenLower TargetOutperform$75.00 ➝ $55.00Low
8/3/2022CowenLower TargetOutperform$75.00 ➝ $55.00Low
8/3/2022StephensDowngradeOverweight ➝ Equal Weight$80.00 ➝ $45.00Low
8/3/2022Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$65.00Low
8/1/2022Needham & Company LLCLower TargetBuy$80.00 ➝ $60.00Low
6/23/2022The Goldman Sachs GroupLower TargetSell$59.00 ➝ $41.00Low
6/9/2022Raymond JamesLower Target$90.00 ➝ $80.00High
5/31/2022Morgan StanleyLower TargetEqual Weight$68.00 ➝ $52.00Low
5/26/2022UBS GroupLower TargetNeutral$80.00 ➝ $50.00Low
5/10/2022CowenLower Target$95.00 ➝ $75.00Low
5/10/2022CowenLower Target$95.00 ➝ $75.00Medium
4/7/2022Morgan StanleyBoost TargetEqual Weight$75.00 ➝ $80.00Low
3/7/2022The Goldman Sachs GroupLower TargetSell$77.00 ➝ $67.00Low
2/18/2022Needham & Company LLCReiterated RatingBuy$95.00Low
2/18/2022Morgan StanleyLower TargetEqual Weight$83.00 ➝ $75.00High
2/18/2022DA DavidsonLower Target$85.00 ➝ $80.00High
2/18/2022JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$80.00 ➝ $68.00High
1/25/2022Daiwa Capital MarketsUpgradeNeutral ➝ Buy$81.00 ➝ $75.00High
1/14/2022Morgan StanleyLower TargetEqual Weight$85.00 ➝ $83.00Low
1/14/2022CowenLower Target$100.00 ➝ $95.00Low
11/12/2021CowenLower TargetOutperform$110.00 ➝ $100.00Low
11/12/2021Morgan StanleyUpgradeUnderweight ➝ Equal Weight$78.00 ➝ $85.00Low
11/8/2021Northcoast ResearchUpgradeNeutral ➝ BuyMedium
11/8/2021Needham & Company LLCUpgradeHold ➝ Buy$95.00Low
11/8/2021Raymond JamesLower TargetStrong-Buy$120.00 ➝ $110.00High
10/7/2021Morgan StanleyLower TargetUnderweight$79.00 ➝ $74.00Low
8/10/2021DA DavidsonReiterated RatingNeutralMedium
8/6/2021HSBCDowngradeBuy ➝ Hold$92.00Low
8/6/2021Needham & Company LLCReiterated RatingHoldHigh
5/19/2021Raymond JamesUpgradeOutperform ➝ Strong-Buy$100.00 ➝ $120.00Medium
5/7/2021Morgan StanleyBoost TargetUnderweight$68.00 ➝ $72.00Low
2/12/2021CowenBoost TargetOutperform$85.00 ➝ $105.00Low
2/12/2021Raymond JamesBoost TargetOutperform$75.00 ➝ $100.00Low
2/12/2021Morgan StanleyBoost TargetUnderweight$62.00 ➝ $68.00Low
1/20/2021Morgan StanleyBoost TargetUnderweight$57.00 ➝ $62.00Low
1/14/2021HSBCUpgradeHold ➝ BuyMedium
10/29/2020Morgan StanleyBoost TargetUnderweight$55.00 ➝ $57.00High
10/29/2020Robert W. BairdUpgradeUnderperform ➝ Neutral$63.00High
10/16/2020StephensInitiated CoverageOverweight$85.00Medium
9/4/2020Daiwa Capital MarketsDowngradeOutperform ➝ NeutralHigh
8/25/2020Wolfe ResearchInitiated CoverageUnderperform$47.00Medium
7/31/2020Morgan StanleyBoost TargetUnderweight$39.00 ➝ $55.00Medium
6/2/2020Robert W. BairdDowngradeNeutral ➝ Underperform$44.00 ➝ $45.00High
5/25/2020HSBCInitiated CoverageHold$55.00Medium
5/8/2020UBS GroupBoost TargetNeutral$43.00 ➝ $56.00Low
4/28/2020Robert W. BairdBoost TargetNeutral$39.00 ➝ $44.00Medium
4/28/2020Morgan StanleyBoost TargetUnderweight$36.00 ➝ $39.00Medium
4/28/2020Raymond JamesBoost TargetOutperform$48.00 ➝ $60.00High
4/17/2020JPMorgan Chase & Co.Boost TargetUnderweight$36.00 ➝ $40.00Low
3/23/2020Morgan StanleyDowngradeEqual Weight ➝ Underweight$42.00 ➝ $36.00High
3/17/2020Morgan StanleyLower TargetEqual Weight$49.00 ➝ $42.00High
2/19/2020Morgan StanleyBoost TargetEqual Weight$47.00 ➝ $49.00Medium
12/12/2019UBS GroupInitiated CoverageNeutral$52.00High
11/1/2019Morgan StanleySet TargetHold$47.00Medium
10/29/2019Needham & Company LLCReiterated RatingHoldLow
9/24/2019Daiwa Capital MarketsSet TargetHold$53.00Low
9/23/2019DA DavidsonBoost TargetNeutral$40.00 ➝ $45.00Low
9/23/2019Robert W. BairdBoost TargetNeutral$42.00 ➝ $47.00Low
9/23/2019CowenReiterated RatingOutperform$50.00 ➝ $60.00Low
7/16/2019The Goldman Sachs GroupDowngradeNeutral ➝ Sell$45.00 ➝ $36.00High
7/10/2019Morgan StanleyLower TargetEqual Weight$47.00 ➝ $43.00Medium
5/3/2019Morgan StanleySet TargetHold$47.00Low
4/30/2019Needham & Company LLCDowngradeBuy ➝ HoldHigh
4/30/2019Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$46.00High
4/17/2019Gordon HaskettInitiated CoverageHold ➝ Hold$54.00Low
2/12/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$47.00 ➝ $50.00High
12/13/2018Needham & Company LLCReiterated RatingBuy ➝ Buy$45.00 ➝ $47.00High
11/19/2018Berenberg BankInitiated CoverageBuy ➝ Buy$54.00High
11/1/2018Daiwa Capital MarketsSet TargetBuy$49.00Low
10/30/2018Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$52.00 ➝ $40.00Medium
10/30/2018Needham & Company LLCLower TargetBuy ➝ Buy$52.00 ➝ $45.00High
10/16/2018Needham & Company LLCUpgradeHold ➝ Buy$52.00High
10/11/2018Morgan StanleySet TargetHold$57.00 ➝ $52.00High
10/2/2018DA DavidsonInitiated CoverageNeutral$57.00Low
8/24/2018Northcoast ResearchDowngradeBuy ➝ Neutral$54.00Medium
8/20/2018Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$57.00Medium
8/1/2018Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$40.10High
7/31/2018Northcoast ResearchSet TargetBuy$56.00High
7/31/2018Robert W. BairdReiterated RatingHold$48.00High
5/7/2018JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$42.00Low
5/1/2018Raymond JamesUpgradeMarket Perform ➝ OutperformHigh
5/1/2018Robert W. BairdLower TargetNeutral ➝ Neutral$62.00 ➝ $40.00High
5/1/2018JPMorgan Chase & Co.Lower TargetNeutral ➝ Hold$62.50 ➝ $42.00High
4/10/2018The Goldman Sachs GroupDowngradeBuy ➝ Neutral$78.00 ➝ $55.00High
4/4/2018Northcoast ResearchUpgradeNeutral ➝ BuyHigh
4/3/2018JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$63.00Low
1/19/2018Deutsche Bank AktiengesellschaftSet TargetBuy ➝ Buy$80.00Low
(Data available from 12/8/2017 forward)

News Sentiment Rating

0.64 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/12/2022
  • 1 very positive mentions
  • 8 positive mentions
  • 6 negative mentions
  • 0 very negative mentions
6/11/2022
  • 3 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
7/11/2022
  • 4 very positive mentions
  • 20 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
8/10/2022
  • 5 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
9/9/2022
  • 6 very positive mentions
  • 16 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
10/9/2022
  • 1 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
11/8/2022
  • 4 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/8/2022

Current Sentiment

  • 4 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Cognex logo
Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. The company offers VisionPro software, a suite of patented vision tools for advanced programming; QuickBuild that allows customers to build vision applications with a graphical, flowchart-based programming interface; and Cognex deep learning vision software. It also provides a range of inspection tasks, including part location, identification, measurement, assembly verification, and robotic guidance; vision sensors for vision applications, such as checking the presence and size of parts; and the In-Sight product line of vision systems and sensors. In addition, the company offers DataMan, an image-based barcode readers and barcode verifiers. It sells its products to consumer electronics, automotive, consumer products, food and beverage, pharmaceuticals, and medical devices industries, as well as through a network of distributors and integrators. Cognex Corporation was incorporated in 1981 and is headquartered in Natick, Massachusetts.
Read More

Today's Range

Now: $49.77
Low: $48.42
High: $49.92

50 Day Range

MA: $46.26
Low: $40.88
High: $51.21

52 Week Range

Now: $49.77
Low: $40.21
High: $80.30

Volume

1,261,082 shs

Average Volume

1,014,063 shs

Market Capitalization

$8.61 billion

P/E Ratio

41.13

Dividend Yield

0.58%

Beta

1.58

Frequently Asked Questions

What sell-side analysts currently cover shares of Cognex?

The following Wall Street analysts have issued reports on Cognex in the last year: Cowen Inc, Cowen Inc., DA Davidson, Daiwa Capital Markets, JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Raymond James, Sanford C. Bernstein, Stephens, StockNews.com, The Goldman Sachs Group, Inc., TheStreet, and UBS Group AG.
View the latest analyst ratings for CGNX.

What is the current price target for Cognex?

12 Wall Street analysts have set twelve-month price targets for Cognex in the last year. Their average twelve-month price target is $52.92, suggesting a possible upside of 6.3%. DA Davidson has the highest price target set, predicting CGNX will reach $80.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $40.00 for Cognex in the next year.
View the latest price targets for CGNX.

What is the current consensus analyst rating for Cognex?

Cognex currently has 2 sell ratings, 5 hold ratings, 3 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CGNX, but not buy more shares or sell existing shares.
View the latest ratings for CGNX.

What other companies compete with Cognex?

How do I contact Cognex's investor relations team?

Cognex's physical mailing address is ONE VISION DRIVE, NATICK MA, 01760. The scientific and technical instruments company's listed phone number is (508) 650-3000 and its investor relations email address is [email protected] The official website for Cognex is www.cognex.com. Learn More about contacing Cognex investor relations.